【レポートの概要（一部）】
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Product profiles
PART 05: Introduction
Key market highlights
PART 06: Disease overview
Understanding the disease
Risk factors
Signs and symptoms
Diagnosis
Staging
Treatment
Epidemiology
PART 07: Pipeline portfolio
Information on pipeline candidates
PART 08: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 09: Market segmentation by molecule type
Biologics
Small molecules
PART 10: Market segmentation by route of administration
Oral
Parenteral
PART 11: Geographical segmentation
PART 12: Market drivers
PART 13: Impact of drivers
PART 14: Market challenges
PART 15: Impact of drivers and challenges
PART 16: Market trends
PART 17: Vendor landscape
Competitive scenario
Market analysis 2014
Other prominent vendors
PART 18: Key vendor analysis
AstraZeneca
Celgene
Eli Lilly
F. Hoffmann-La Roche
Pfizer
PART 19: Appendix
List of abbreviations
PART 20: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Types of non-small cell lung cancer
Exhibit 03: Gene mutations in non-small cell lung cancer
Exhibit 04: Risk factors for non-small cell lung cancer
Exhibit 05: Signs and symptoms of non-small cell lung cancer
Exhibit 06: Tests for diagnosis of non-small cell lung cancer
Exhibit 07: Staging of non-small cell lung cancer
Exhibit 08: Management of non-small cell lung cancer
Exhibit 09: Types of radiation therapy for non-small cell lung cancer
Exhibit 10: Photodynamic therapy uses light to actuate a drug in the body, which kills abnormal cells.Non-small cell lung cancer treatment algorithm
Exhibit 11: Phase III pipeline molecules for non-small cell lung cancer
Exhibit 12: Global non-small cell lung cancer therapeutics market 2014-2019 ($ billions)
Exhibit 13: Five forces analysis
Exhibit 14: Global non-small cell lung cancer therapeutics market segmentation by molecule type
Exhibit 15: Global non-small cell lung cancer therapeutics market segmentation by route of administration
Exhibit 16: Global non-small cell lung cancer market by geographical segmentation 2014
Exhibit 17: Impact of drivers
Exhibit 18: Impact of drivers and challenges
Exhibit 19: F. Hoffmann-La Roche: Global YoY growth and revenue of Avastin 2011-2014 ($ millions)
Exhibit 20: F. Hoffmann-La Roche: Key takeaways
Exhibit 21: Alimta: Global YoY growth and revenue 2011-2014 ($ millions)
Exhibit 22: Gemzar: Global YoY growth and revenue 2008-2011 ($ millions)
Exhibit 23: Eli Lilly: Key takeaways
Exhibit 24: Abraxane: Global YoY growth and revenue 2011-2014 ($ millions)
Exhibit 25: Celgene: Key takeaways
Exhibit 26: Iressa: Global YoY growth and revenue 2011-2014 ($ millions)
Exhibit 27: Iressa: YoY growth and revenue in Western Europe 2011-2014 ($ millions)
Exhibit 28: Iressa: YoY growth and revenue in established ROW 2011-2014 ($ millions)
Exhibit 29: Iressa: YoY growth and revenue in emerging markets 2011-2014 ($ millions)
Exhibit 30: AstraZeneca: Key takeaways
Exhibit 31: Xalkori: Global YoY growth and revenue 2012-2014 ($ millions)
Exhibit 32: Pfizer: Key takeaways
Exhibit 33: AstraZeneca: Business segmentation by revenue 2014
Exhibit 34: AstraZeneca: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 35: AstraZeneca: Geographical segmentation by revenue 2014
Exhibit 36: Celgene: Product segmentation by revenue 2014
Exhibit 37: Celgene: Product segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 38: Celgene: Geographical segmentation by revenue 2014
Exhibit 39: Eli Lilly: Business segmentation by revenue 2014
Exhibit 40: Eli Lilly: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 41: Eli Lilly: Geographical segmentation by revenue 2014
Exhibit 42: F. Hoffmann-La Roche: Business segmentation by revenue 2014
Exhibit 43: F. Hoffmann-La Roche: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 44: F. Hoffmann-La Roche: Geographical segmentation by revenue 2014
Exhibit 45: Pfizer: Business segmentation by revenue 2014
Exhibit 46: Pfizer: Geographical segmentation by revenue 2014
【レポート販売概要】
■ タイトル：非小細胞肺がん治療薬の世界市場2015-2019■ 英文：Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019
■ 発行日：2015年10月21日
■ 調査会社：Technavio
■ 商品コード：IRTNTR7475
■ 調査対象地域：グローバル
- Sabine Royalty Trust：石油・ガスの開発・生産動向及びコスト分析- Q1, 2013Sabine Royalty Trust Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Sabine Royalty Trust Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source f …
- Empagliflozin (Type 2 Diabetes)：市場予測と分析（～2022）Empagliflozin (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “Empagliflozin (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being marked by a late-stage pipeline filled with me-too drugs, this market will undergo substantial growth between 2012 an …
- 種子処理の世界市場予測（～2021）The global seed treatment market has grown exponentially in the last few years. The market size is projected to reach USD 9.82 Billion by 2021, at a CAGR of around 10.8% from 2016 to 2021. The growing global population and resultant food requirements are the main driving factors of this market. The seed treatment market based on function is segmented into crop protection chemicals and seed enhance …
- 成形材料の世界市場：フェノール樹脂、エポキシ樹脂、ポリエステル樹脂The global molding compound market by thermoset resin type to grow from USD 8.04 Billion in 2015 to USD 10.96 Billion by 2020, at a compound annual growth rate (CAGR) of 6.40% between 2015 and 2020. The global market by thermoset resin type has witnessed a strong growth in the past few years considering the high demand from the electrical application market. Thermoset molding compounds provides an …
- 食品加工機械の世界市場2016-2020About Food Processing Machinery Food processing equipment is used by manufacturers of food products for processing food using techniques such as blending, homogenization, pasteurization, and filling. Processing of food helps in removal of toxins and preservation. Processed food offers advantages such as enhanced taste, low risk of contamination, enhanced shelf life, and a high degree of portabilit …
- 冷媒の世界市場：フルオロカーボン系冷媒、無機冷媒、炭化水素The refrigerants market is projected to register a CAGR of 6.0% between 2015 and 2020 to reach $21 billion. Increasing demand of cooling products, high growth in Asia-Pacific region and growing cold chain market are the main growth drivers for refrigerant market. Asia-Pacific is the fastest growing region in the global refrigerants market. The countries dominating in the Asia-Pacific region are Ch …
- 自動コンテナターミナルの世界市場2017-2021About Automated Container Terminal Automated container terminals use container handling equipment that requires no human interaction and can be operated using hardware, software, and terminal operating systems (TOS). The first container terminal with full automation features became operational two decades ago. The initial automated container terminal was in the Netherlands, (ECT Delta). The contai …
- 顕微鏡の世界市場：光学顕微鏡（蛍光顕微鏡、超解像顕微鏡）、共焦点顕微鏡、電子顕微鏡The global microscopy market is poised to reach USD 6.72 Billion by 2021 from USD 4.68 Billion in 2016, at a CAGR of 7.5% from 2016 to 2021. In this report, the global microscopy market is broadly segmented by product, application, end user, and region. Major factors fueling market growth are the rising global focus on nanotechnology, favorable government and corporate funding, and technological a …
- 逆浸透膜の世界市場：材料別、フィルターモジュール別、用途別The reverse osmosis (RO) membrane is a material with tiny pores that exclude dissolved salts and molecules from sea or brackish water. RO is the most economical and practical way for purification & treatment of water. The RO membrane is delicate and expensive, hence needs protection. Since its discovery, there has been progressive improvement in the membranes and development of means for packaging …
- CRMにおけるビックデータ（Big Data in Customer Relationship Management (CRM)）Customer Relationship Management (CRM) is a model of managing relationship and interaction between company and customer. This includes using technology for organizing, automating, and synchronizing all customer-related information like sales, marketing, services, support and more. Big Data represents more than just a collection of data sets that form a large quantity of data, which is difficult to …
- 家庭用ベビー動き監視モニターの世界市場2016-2020About the Home-Use Baby Movement Monitor Market Baby movement monitors are gaining traction across the world due to the introduction of new smart formats with additional functionalities. New parents adopt baby movement monitors to ensure the safety of their child. Tech-savvy consumers, especially parents who use baby care apps, are also the key end-users of baby movement monitors. These devices tr …
- 世界のシアン化水素市場2015The Global Hydrogen Cyanide (HCN) Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Hydrogen Cyanide (HCN) industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Hydrogen Cyanide (HCN) market analysis is provided for the international markets including d …
- ノルウェーの石油・ガス産業における中流（Midstream）市場展望Norway Midstream Oil and Gas Industry Outlook to 2020: Market Forecasts for Liquefied Natural Gas (LNG), Oil Storage, Pipelines and Gas Processing Summary "Norway Midstream Oil and Gas Industry Outlook to 2020: Market Forecasts for Liquefied Natural Gas (LNG), Oil Storage, Pipelines and Gas Processing" is a comprehensive report on midstream oil and gas industry in Norway. The report provides oil p …
- 心室頻拍(Ventricular Tachycardia)：世界の治験レビュー（2015年上半期版）Ventricular Tachycardia Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Ventricular Tachycardia Global Clinical Trials Review, H1, 2015" provides data on the Ventricular Tachycardia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ventricular Tachycardia. It includes an overview of the trial numbers …
- 片頭痛（Migraine）：企業動向PharmaPoint: Migraine - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Migraine - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Migraine Market. The report identifies and analyses the key companies shaping and driving the global Migraine market. The repo …
